Kopciuch, D.; Hoffmann, K.; Kus, K.; Koligat-Seitz, A.; Ratajczak, P.; Nowakowska, E.; Paczkowska, A. Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland. Vaccines2024, 12, 341.
Kopciuch, D.; Hoffmann, K.; Kus, K.; Koligat-Seitz, A.; Ratajczak, P.; Nowakowska, E.; Paczkowska, A. Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland. Vaccines 2024, 12, 341.
Kopciuch, D.; Hoffmann, K.; Kus, K.; Koligat-Seitz, A.; Ratajczak, P.; Nowakowska, E.; Paczkowska, A. Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland. Vaccines2024, 12, 341.
Kopciuch, D.; Hoffmann, K.; Kus, K.; Koligat-Seitz, A.; Ratajczak, P.; Nowakowska, E.; Paczkowska, A. Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland. Vaccines 2024, 12, 341.
Abstract
Background: Annual influenza epidemics are a serious public health problem, causing particularly severe morbidity and mortality in high-risk groups. The study aimed to understand Poles' attitudes and beliefs towards influenza vaccinations in the flu season of 2022–2023, analyze preferences and unmet needs regarding influenza vaccinations, and examine the perception and acceptance of the influenza vaccine among individuals at risk of flu complications.
Methods: A cross-sectional survey-based study was carried out on a sample of 1446 respondents.
The Google Forms questionnaire was created and disseminated electronically using social media and e-mail. The pre-test was performed at the beginning of the project.
Results: The majority of respondents (71%) could identify "high-risk groups" recommended for influenza vaccination. Furthermore, it was observed that individuals aged 21 to 59 demonstrated a higher level of knowledge in this regard compared to those below 20 and above 65 years old, and individuals with higher and medium education levels were much better at identifying risk groups for influenza virus infection. The majority of respondents (52.01%) reported receiving influenza vaccination at some point in the past, with 32.12% receiving it in the 2022–2023 flu season and 41.09% in the 2021–2022 season. The majority of respondents declaring acceptance of the vaccine for the 2022-2023 season were in the high-risk group. Only 17.28% of respondents declared receiving both influenza and SARS-CoV-2 vaccines in the 2022-2023 season, with the vast majority being respondents from the "high-risk group" (p
Keywords
vaccines; influenza; high-risk groups; attitudes; practice
Subject
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
